Literature DB >> 19169914

Mangafodipir as a cytoprotective adjunct to chemotherapy--a case report.

Olav Erich Yri, Jens Vig, Elisabeth Hegstad, Oistein Hovde, Ingrid Pignon, Per Jynge.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19169914     DOI： 10.1080/02841860802680427

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  8 in total

1.  First clinical experience with the magnetic resonance imaging contrast agent and superoxide dismutase mimetic mangafodipir as an adjunct in cancer chemotherapy-a translational study.

Authors:  Jan Olof G Karlsson; Karin Adolfsson; Bo Thelin; Per Jynge; Rolf Gg Andersson; Ursula G Falkmer
Journal:  Transl Oncol       Date:  2012-02-01       Impact factor: 4.243

2.  Manganese Uptake and Accumulation in the Human Brain.

Authors:  V Blomlie; R Sivanandan; P Jynge
Journal:  AJNR Am J Neuroradiol       Date:  2020-01-02       Impact factor: 3.825

3.  Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.

Authors:  Jan Olof G Karlsson; Tino Kurz; Susanne Flechsig; Jacques Näsström; Rolf Gg Andersson
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

Review 4.  Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Authors:  Jan Olof G Karlsson; Rolf Gg Andersson; Per Jynge
Journal:  Transl Oncol       Date:  2017-06-29       Impact factor: 4.243

Review 5.  Manganese-Enhanced Magnetic Resonance Imaging: Overview and Central Nervous System Applications With a Focus on Neurodegeneration.

Authors:  Ryan A Cloyd; Shon A Koren; Jose F Abisambra
Journal:  Front Aging Neurosci       Date:  2018-12-13       Impact factor: 5.750

Review 6.  MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.

Authors:  Per Jynge; Arne M Skjold; Ursula Falkmer; Rolf G G Andersson; John G Seland; Morten Bruvold; Viggo Blomlie; Willy Eidsaunet; Jan O G Karlsson
Journal:  Contrast Media Mol Imaging       Date:  2020-09-04       Impact factor: 3.161

7.  Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer.

Authors:  Yi Zhang; Chao Li; Yi Qin; Pasquale Cepparulo; Michael Millman; Michael Chopp; Amy Kemper; Alexandra Szalad; Xuerong Lu; Lei Wang; Zheng Gang Zhang
Journal:  J Extracell Vesicles       Date:  2021-03-04

8.  The Damaging Outcome of the POLAR Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction between Oxaliplatin and PledOx.

Authors:  Jan Olof G Karlsson; Per Jynge; Louis J Ignarro
Journal:  Antioxidants (Basel)       Date:  2021-12-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.